statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of CareDx, Inc. (NASDAQ: CDNA)

SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of CareDx, Inc. (NASDAQ: CDNA) SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of CareDx...

CareDx to Report Second Quarter 2024 Financial Results

CareDx, Inc. (Nasdaq: CDNA) The Transplant Company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients...

Landmark Independent Publication in Nature Medicine Validates CareDx AlloView AI-Enabled Risk Prediction Model and Demonstrates AlloSure Kidney Detects Subclinical Rejection in Stable Patients

AI Integration and Real-World Utility of CareDx Portfolio Highlighted in New Data at the 2024 American Transplant Congress

CareDx, Inc. (Nasdaq: CDNA) The Transplant Company a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value...

CareDx Reiterates Position that it Does Not Infringe the 544 Patent, Injunction Motion is Irrelevant

CareDx to Participate in Upcoming Investor Conferences

CareDx, Inc. (Nasdaq: CDNA), The Transplant Company a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value...

Landmark Study Shows CareDxs HeartCare Outperforms dd-cfDNA Alone in Identifying Rejection and Patients Experienced Excellent Outcomes with Fewer Biopsies

Navigating 5 Analyst Ratings For CareDx

Latest Ratings for CDNA
 DateFirmActionFromTo Feb 2022Raymond JamesMaintainsStrong Buy Oct 2021Raymond JamesMaintainsStrong Buy Jun 2021Raymond JamesMaintainsStrong Buy
 View More Analyst...

CareDx Reports First Quarter 2024 Results

CareDx, Inc. (Nasdaq: CDNA) today reported financial results for the first quarter ended March 31, 2024. First Quarter 2024 Highlights Reported first quarter revenue of $72.0 million. Revenue for...

CareDx Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

CareDx, Inc. operates as a transplant diagnostics company, which discovers, develops and commercializes diagnostic solutions. Its products include AlloMap, AlloSure and Laboratory products. The company was founded on December 21, 1998 and is headquartered in Brisbane, CA.

Caredx Inc

Volume	1.2M
52-Wk High	$19.58
52-Wk Low	$4.80

CDNA Caredx Inc

About

Feed

News

Sentiment

Earnings

Fundamentals